MiRNA Sequencing and Assay Market Global Industry Trends Opportunities and Forecasts 2020-2030
17 janv. 2025 08h32 HE
|
Research and Markets
Dublin, Jan. 17, 2025 (GLOBE NEWSWIRE) -- The "MiRNA Sequencing and Assay Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2020-2030F" report has been added to ...
ADARx Pharmaceuticals to Present at the J.P. Morgan 43ʳᵈ Annual Healthcare Conference
10 janv. 2025 09h00 HE
|
ADARx Pharmaceuticals
ADARx to present at the JP Morgan Healthcare Conference
Cytosurge Announces Strategic Leadership Transition
09 janv. 2025 10h25 HE
|
Cytosurge AG
Cytosurge appoints Simon Egli as CEO; co-founder Pascal Behr transitions to Board to ensure strategic guidance and growth.
Altamira Therapeutics Announces Successful Nanoparticle-Based Delivery of Circular RNA
31 déc. 2024 09h00 HE
|
Altamira Therapeutics Ltd
Hamilton, Bermuda, Dec. 31, 2024 (GLOBE NEWSWIRE) -- Further proof of great versatility of Altamira’s platform for extrahepatic RNA deliveryCircular mRNA significantly increasing protein expression...
TransCode Therapeutics, Inc. Announces $8 Million Private Placement
27 nov. 2024 07h00 HE
|
TransCode Therapeutics, Inc.
TransCode Therapeutics, Inc. Announces $8 Million Private Placement
Baylor Genetics Wins BioTech Breakthrough Award
19 nov. 2024 10h00 HE
|
Baylor Genetics
Baylor Genetics announced its selection as the 2024 winner of the “Overall Genomics Solution of the Year" from BioTech Breakthrough.
North America RNA Therapeutics Market Research 2024-2029: Revolutionary Advancements in RNA Technology and Personalized Medicine Propel Growth
14 nov. 2024 05h21 HE
|
Research and Markets
Dublin, Nov. 14, 2024 (GLOBE NEWSWIRE) -- The "North America RNA Therapeutics Market, By Country, Competition, Forecast & Opportunities, 2019-2029F" report has been added to ...
Cell And Gene Therapy Market Size to Worth USD 190.82 Billion by 2033 | Straits Research
07 nov. 2024 09h30 HE
|
Straits Research Private Limited - Garner Insights
New York, United States , Nov. 07, 2024 (GLOBE NEWSWIRE) -- “Cell therapy” refers to the process of administering live cells to patients with the purpose of treating various diseases. Both...
TransCode Therapeutics Announces Safety Review Committee Approval of Second Cohort Opening in Phase 1 TTX-MC138 Clinical Trial Following Favorable Review of Cohort 1 Safety Data
23 oct. 2024 07h00 HE
|
TransCode Therapeutics, Inc.
TransCode Therapeutics Announces Safety Review Committee Approval of Second Cohort Opening in Phase 1 TTX-MC138 Clinical Trial Following Favorable Review o
Cytosurge and Lexogen Partner to Advance Live-Cell Sequencing
15 oct. 2024 09h00 HE
|
Cytosurge AG; Lexogen GmbH
Cytosurge and Lexogen partner to advance Live-seq, integrating FluidFM® and LUTHOR HD to enable scalable, live-cell transcriptomics with high sensitivity.